Hydreight's Oct. 22 cash at $18.7-million

Mr. Shane Madden reports HYDREIGHT REPORTS CORPORATE UPDATE AND RANKS #25 ON DELOITTE'S 2025 TECHNOLOGY FAST 50(TM) Hydreight Technologies Inc. has provided a corporate update, alongside a series of prestigious recognitions highlighting the company's growth and innovation across North America. Hydreight ranked No. 25 on Deloitte's 2025 Technology Fast 50 (Canada) for its revenue growth from 2021 to 2024, and was previously ranked No. 56 on Deloitte's 2024 Technology Fast 500 (U.S.). The company was also: Recognized on the 2025 list as a Top 50 TSX Venture Exchange company for 2024; Selected as a finalist for the Company of the Year -- Scale Award at the B.C. Tech Association's 2025 Technology Impact Awards (TIAs); Announced as a Pacific region finalist for the EY Entrepreneur of the Year Canada 2025 Awards. These achievements collectively underscore Hydreight's leadership in modernizing health care delivery through technology, compliance and nationwide scalability. Hydreight operates one of the largest fully compliant telehealth and medical networks in the United States, connecting health care providers, pharmacies and patients through its proprietary VSDHOne platform across all 50 states. Recent company highlights: Approximately 295,000 VSDHOne product orders processed between July and September, reflecting broad growth across GLP-1 weight management, hormone therapy, NAD (nicotinamide adenine dinucleotide), hair restoration, genetic testing, ondanestron and more; Nurse network expansion: 198 new nurse sign-ups between July and September versus 133 during the same period last year (up 49 per cent year over year); 593 sign-ups in the first nine months of 2025 versus 364 in 2024 (approximately 63 per cent year over year); pharmacy orders (excluding VSDHOne) increased approximately 72 per cent year over year, reflecting sustained growth and broader adoption across multiple wellness verticals; Balance sheet: enhanced liquidity following an oversubscribed $11.5-million convertible debenture financing closed Sept. 4, 2025, bringing the company's cash position to approximately $18.7-million at Oct. 22, 2025; Infrastructure and technology growth: further integration of 503A/503B pharmacy partners to increase capacity, fulfilment speed and margin potential, alongside the coming release of VSDHOne V2 -- an enhanced version of the company's telehealth platform designed to deliver greater automation, scalability and modular functionality for partners nationwide; GLP-1 and D2C (direct-to-consumer) expansion: continuing national rollout of Dr. Franklin Joseph's GLP-1 program and additional direct-to-consumer wellness offerings on VSDHOne; M&A (merger and acquisition) pipeline: active evaluation of profitable multistate wellness and digital health operators that can scale nationally through VSDHOne. Management commentary "Hydreight's recognition by Deloitte as one of Canada's fastest-growing technology companies is a validation of our model and execution," said Shane Madden, chief executive officer of Hydreight Technologies. "Our performance from July to September demonstrates the strength and scalability of our compliant health care infrastructure. With approximately $18.7-million in cash, we're well positioned to accelerate growth across our GLP-1, D2C and pharmacy network initiatives while continuing to execute profitably and responsibly." Strategic progress: Direct to consumer (D2C): VSDHOne continues to accelerate D2C initiatives, allowing health care and wellness brands to launch nationwide in days instead of months; GLP-1 vertical: expansion of Dr. Joseph's GLP-1 program to meet surging patient demand; Pharmacy network: deeper integration with 503A/503B partners to improve fulfilment speed and margin profile; Technology advancement: VSDHOne's modular design lets partners adopt telehealth, compliance and pharmacy modules individually, expanding Hydreight's addressable market. Capital markets and investor engagement: Analyst coverage: initiated by Maxim Group and Beacon Securities (reports available to qualified investors upon request); Industry recognition: ranked No. 25 on Deloitte's 2025 Technology Fast 50 (Canada) and previously ranked No. 56 on Deloitte's 2024 Technology Fast 500 (U.S.); also recognized in the 2025 TSX Venture Top 50; Investor conferences: CEM Muskoka Capital Event -- Sept. 26 to Sept. 28, 2025 (Top Pick recognition); Smallcap Discoveries Investor Event -- Sept. 29 to Sept. 30, 2025 (Vancouver, B.C.); Planet MicroCap Showcase -- Toronto -- Oct. 22 to Oct. 23, 2025 (Toronto, Ont.): Presentation: Wednesday, Oct. 22, 2025, at 5:30 p.m. ET (Arcadian Loft); One-on-one meetings: Wednesday, Oct. 22, 2025, and Thursday, Oct. 23, 2025 (in person at Arcadian Loft). Outlook Hydreight enters Q4 2025 with strong operational momentum and a solid cash position to finance growth initiatives across GLP-1, D2C and pharmacy integrations. The company remains focused on profitable, compliant expansion and long-term shareholder value as it continues to scale its telehealth infrastructure nationally. About Hydreight Technologies Inc. Hydreight Technologies is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform has hosted a network of over 3,000 nurses, over 200 doctors and a pharmacy network through its doctor networks across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, which enables licensed health care professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed health care professionals. The Hydreight platform allows health care professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network. About VSDHOne -- direct-to-consumer platform Developed in partnership with Victory Square Technologies, Hydreight Technologies launched the VSDHOne (read as VSDH-One) platform. VSDHOne simplifies the entry challenges for companies and medi-spa businesses to enter the on-line health care space compliantly. This platform will help all businesses to launch a direct-to-consumer health care brand in a matter of days in all 50 states. compliant offerings include: GLP-1s, peptides, personalized health care treatments, sermorelin, testosterone replacement therapy (TRT), hair loss, skin care, sexual health and more. Hydreight invested in technology, legal and infrastructure to launch this platform. The VSDHOne platform offers a complete, and modular end-to-end solution for businesses looking to launch direct-to-consumer health care brands. From compliance and telemedicine technology to nationwide doctor and pharmacy networks, VSDHOne provides all the tools needed for a seamless entry into the on-line health care space. The platform is designed to significantly reduce the time and costs associated with launching such services, making it possible for businesses to go live in days instead of months. We seek Safe Harbor.